Alameda, CA, United States of America

Mina A Nashed


Average Co-Inventor Count = 5.0

ph-index = 2

Forward Citations = 46(Granted Patents)


Location History:

  • Alexandria, EG (1996)
  • Alameda, CA (US) (1994 - 1998)

Company Filing History:


Years Active: 1994-1998

Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Mina A. Nashed

Introduction

Mina A. Nashed is a prominent inventor based in Alameda, CA, known for her significant contributions to the field of biomedical research. With a focus on inflammation and cancer treatment, she has developed innovative methods that have the potential to impact patient care positively. Her work has led to the filing of several patents, showcasing her expertise and dedication to advancing medical science.

Latest Patents

Mina A. Nashed holds 4 patents, with her latest inventions focusing on methods of treating inflammation using cell adhesion inhibitors. These patents describe compounds and methods that bind to selectin receptors, modulating the course of inflammation, cancer, and related diseases by influencing cell-cell adhesion events. The detailed chemical formulas provided in her patents highlight the complexity and potential of her work in developing effective treatments.

Career Highlights

Mina is currently associated with Glycomed, Inc., where she continues to innovate and contribute to the field of biomedical research. Her career is marked by a commitment to understanding and addressing critical health issues through scientific inquiry and invention.

Collaborations

Throughout her career, Mina has collaborated with notable colleagues, including Saeed A. Abbas and Darwin S. Asa. These partnerships have fostered a collaborative environment that enhances the research and development of new therapeutic approaches.

Conclusion

Mina A. Nashed's work exemplifies the spirit of innovation in the biomedical field. Her patents and ongoing research efforts are paving the way for new treatments that could significantly improve health outcomes for patients suffering from inflammation and cancer.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…